Boulder, Colorado - November 10, 2006 - Bolder BioTechnology, Inc. today announced that it has been awarded a $775,848 Phase II Small Business Innovation Research (SBIR) grant from the National Cancer Institute of The National Institutes of Health (NIH). The grant will be used to perform preclinical efficacy and pharmacology studies of the company's proprietary long-acting…Read more
Recent Posts by admbbt
Boulder, Colorado – March 3, 2006 - Bolder BioTechnology, Inc. is pleased to announce that it has relocated its research operations and corporate headquarters to 2945 Wilderness Place, Suite 100, Boulder, Colorado 80301. The Boulder facility includes approximately 8,500 square feet of laboratory and office space. CRESA Partners of Denver, Colorado provided brokerage services and advised…Read more
Recent Comments by admbbt
No comments by admbbt yet.